InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Stankovic Srdjan R., Directeur Comptable. Director active across 1 companies, notably Acadia Pharmaceuticals INC. Aggregated, 8 filings have been recorded. The latest transaction was filed on 23 February 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations8 total
9,616 shares
Common Stock
SEC:0001209191-22-026940:0·
04,919 shares0
Common Stock
SEC:0001209191-22-013275:0·
5,444 shares
Common Stock
SEC:0001209191-22-002749·
5,444 shares
Common Stock
SEC:0001209191-22-002749:0·
6,250 shares
Common Stock
SEC:0001209191-21-066570·
6,250 shares
Common Stock
SEC:0001209191-21-066570:0·
2,969 shares
Common Stock
SEC:0001209191-21-060958·
2,969 shares
Common Stock
SEC:0001209191-21-060958:0·
8 of 8 declarations
About Stankovic Srdjan R.
Christopher G. Lee serves as Chief Accounting Officer at Apria, Inc. In this role, he oversees the company's accounting and financial operations, ensuring compliance and accuracy of financial reporting. Christopher plays a vital role in managing Apria's finances and supporting strategic decisions.
